Citalopram is a selective serotonin reuptake inhibitor (SSRI) used primarily to treat major depressive disorder in adults. By increasing serotonin in the brain, it can improve mood, energy, and daily functioning. Many people notice benefits within 1–4 weeks, with continued gains over 8–12 weeks. It is generally taken once daily and is available as tablets or oral solution. Like all antidepressants, citalopram has potential side effects and drug interactions, and it should not be stopped suddenly. In the United States, it is a prescription-only medicine, so guidance from a licensed clinician is essential before starting, adjusting, or discontinuing therapy safely.
Citalopram is an SSRI antidepressant indicated for the treatment of major depressive disorder (MDD) in adults. By selectively inhibiting the reuptake of serotonin, it helps restore neurotransmitter balance associated with mood regulation. Patients typically experience gradual improvements in sleep, appetite, energy, and outlook, with full therapeutic effect developing over several weeks.
Beyond its FDA-approved use in depression, clinicians sometimes prescribe citalopram off-label for conditions such as panic disorder, social anxiety, or obsessive-compulsive symptoms when benefits are expected to outweigh risks. Off-label use should always be individualized and supervised by a qualified healthcare professional who can monitor response and safety.
Citalopram is generally taken once daily, which can support adherence. While it can be effective as monotherapy, it may also be combined with psychotherapy, lifestyle measures (sleep hygiene, exercise), and, in some cases, adjunctive medications to enhance outcomes. This article provides educational information and is not a substitute for personalized medical advice.
Typical adult dosing for major depressive disorder starts at 20 mg once daily. Depending on response and tolerability, clinicians may increase to a maximum of 40 mg once daily after at least one week. Due to the risk of dose-dependent QT prolongation, doses above 40 mg/day are not recommended.
Certain populations require lower maximum doses. For adults over 60 years, those with hepatic impairment, or patients who are CYP2C19 poor metabolizers or receiving strong CYP2C19 inhibitors (for example, omeprazole or cimetidine), the recommended maximum dose is 20 mg once daily. Your prescriber may consider baseline and follow-up ECGs and electrolyte monitoring if you have cardiac risk factors.
Citalopram may be taken with or without food, preferably at the same time each day. Swallow tablets whole with water. If using the oral solution, measure carefully with a marked device. Do not abruptly stop citalopram; when discontinuation is appropriate, a gradual taper over weeks helps reduce withdrawal symptoms such as dizziness, irritability, and sleep disturbance. Never change your dose without medical guidance.
Clinical response is usually seen within 1–4 weeks, with further improvement by 8–12 weeks. If symptoms persist, your clinician may adjust the dose, switch agents, or add therapies based on your history, side effect profile, and treatment goals.
Tell your clinician about all medical conditions, especially heart disease, history of arrhythmia or fainting, recent heart attack, electrolyte abnormalities (low potassium or magnesium), liver problems, seizure disorder, bipolar disorder, glaucoma, bleeding disorders, or low sodium (hyponatremia). Citalopram may worsen or unmask mania/hypomania in people with bipolar spectrum conditions; screening is recommended before starting therapy.
Antidepressants carry a boxed warning about increased risk of suicidal thinking and behavior in children, adolescents, and young adults, particularly during the first months of treatment or after dose changes. Caregivers and patients should monitor for new or worsening mood changes, agitation, or unusual behavior and seek prompt medical attention if they occur.
Citalopram can cause hyponatremia (particularly in older adults and those taking diuretics), bleeding risk (especially when combined with NSAIDs, aspirin, or anticoagulants), and angle-closure glaucoma in susceptible individuals. Avoid alcohol if it worsens sedation or judgment. Use caution with activities requiring alertness until you know how the medicine affects you.
Pregnancy and breastfeeding require individualized risk–benefit discussions. Late-pregnancy SSRI exposure has been associated with neonatal adaptation symptoms and, rarely, persistent pulmonary hypertension of the newborn. Small amounts of citalopram pass into breast milk; monitor infants for irritability, poor feeding, or sleep changes. Citalopram is not approved for pediatric depression; specialized care is needed if considered in younger patients.
Do not use citalopram if you have a known hypersensitivity to citalopram or any formulation component.
Citalopram is contraindicated with monoamine oxidase inhibitors (MAOIs), or within 14 days of stopping an MAOI, and conversely you must wait at least 14 days after stopping citalopram before starting an MAOI. Serious, potentially fatal serotonin syndrome can result from such combinations.
Citalopram is contraindicated with pimozide due to risk of QT prolongation and arrhythmias. Avoid use in patients with known congenital long QT syndrome or persistent QT prolongation unless the potential benefits clearly outweigh risks and specialist monitoring is in place.
Common side effects often improve over time and may include nausea, dry mouth, sweating, tremor, fatigue, drowsiness or insomnia, dizziness, headache, changes in appetite or weight, diarrhea or constipation, and sexual dysfunction (reduced libido, delayed ejaculation, anorgasmia). Dose adjustments or timing changes sometimes help mitigate these effects—discuss options with your clinician.
Serious adverse effects are less common but require immediate attention. These include signs of serotonin syndrome (agitation, confusion, fever, sweating, shivering, muscle rigidity or twitching, diarrhea), allergic reactions (rash, hives, swelling, trouble breathing), severe hyponatremia (headache, confusion, unsteadiness, seizures), seizures, significant bleeding (unusual bruising, black stools), and angle-closure glaucoma (eye pain, vision changes).
Citalopram can prolong the QT interval in a dose-dependent manner, which may lead to arrhythmias such as torsades de pointes in susceptible individuals. Seek urgent care for palpitations, fainting, or unexplained dizziness. Periodic ECGs and electrolyte checks may be advisable for patients at risk.
Sexual side effects are a frequent reason for discontinuation. Options include dose adjustments, switching agents, drug holidays (not advised without supervision), or adjunct therapies. Openly discussing these effects with your prescriber can help tailor a plan that preserves both safety and quality of life.
Risk of serotonin syndrome increases when citalopram is combined with other serotonergic agents, including MAOIs, linezolid or IV methylene blue, triptans, tramadol, fentanyl, meperidine, dextromethorphan, lithium, tryptophan, and herbal products like St. John’s wort. Avoid these combinations unless specifically directed and closely monitored by a clinician.
Medications that affect citalopram metabolism can alter blood levels. Strong CYP2C19 inhibitors (for example, omeprazole, esomeprazole, cimetidine, fluconazole) may raise citalopram concentrations; in such cases, the recommended maximum dose is 20 mg/day. Inducers or inhibitors of CYP3A4 and CYP2D6 may also have modest effects. Always maintain an up-to-date medication list with your healthcare team.
Citalopram may increase bleeding risk when taken with anticoagulants (warfarin, DOACs), antiplatelet drugs (aspirin, clopidogrel), or NSAIDs (ibuprofen, naproxen). Monitor for bruising or bleeding and ask whether gastroprotection is appropriate.
Combining citalopram with other QT-prolonging drugs raises arrhythmia risk. Caution is warranted with certain antiarrhythmics (amiodarone, sotalol), antipsychotics (ziprasidone, haloperidol), certain antibiotics (macrolides, fluoroquinolones), methadone, and others. Correct low potassium or magnesium before and during therapy when relevant. Alcohol may intensify sedation or impair judgment; limit or avoid based on your response.
If you miss a dose of citalopram, take it as soon as you remember unless it is close to the time for your next dose. If it is near the next scheduled dose, skip the missed dose and resume your regular schedule. Do not double up to make up for a missed dose, as this increases side-effect risk without improving efficacy.
Setting daily reminders, using a pill organizer, or aligning your dose with a routine activity (such as brushing teeth) can improve adherence and reduce missed doses.
Citalopram overdose can cause nausea, vomiting, sweating, drowsiness, tremor, rapid heartbeat, blood pressure changes, confusion, seizures, serotonin syndrome, QT prolongation, and potentially life-threatening arrhythmias. If an overdose is suspected, call Poison Help at 1-800-222-1222 (U.S.) or seek emergency medical care immediately. Do not wait for symptoms to appear.
Provide responders with the medication name, strength, amount taken, and time of ingestion, as well as any other substances consumed. Supportive care in a medical setting is often required, and cardiac monitoring may be necessary.
Store citalopram at room temperature (68–77°F or 20–25°C), protected from excess moisture and light. Keep in the original, tightly closed container and out of reach of children and pets. Do not store in bathrooms or other humid areas.
Dispose of unused or expired medication safely. Utilize take-back programs when available, or follow FDA guidance for home disposal if a program is not accessible. Never share prescription medicines with others.
In the United States, citalopram is a prescription-only medication. It is not legal or safe to buy citalopram without a prescription, and purchasing from unverified sources may expose you to counterfeit or substandard products. The FDA’s BeSafeRx resources and the National Association of Boards of Pharmacy (NABP) .pharmacy program can help you identify legitimate pharmacies.
If you are seeking convenient, compliant access to therapy, Surgery Center of Pottsville offers a legal and structured pathway: you can connect with licensed clinicians for evaluation, receive an evidence-based treatment plan, and, when appropriate, have a valid prescription transmitted to a trusted pharmacy for fulfillment. This approach streamlines care without bypassing medical oversight or U.S. prescription laws.
What this means in practice: no “workarounds” or informal sales, no imported or unlabeled products, and no dispensing without a prescriber’s authorization. Instead, you get timely, guideline-aligned evaluation, clear dosing and monitoring plans, and pharmacist-verified medication. For many patients, this telehealth-enabled model reduces delays, improves continuity, and maintains safety standards.
Before starting or switching antidepressants, schedule a consultation to review your symptoms, history, medications, and goals. If citalopram is appropriate, your clinician will issue the prescription and set follow-up. If another option is better, you will receive tailored recommendations. This is the safest and most reliable alternative to attempting to buy citalopram without prescription online.
Citalopram is a selective serotonin reuptake inhibitor (SSRI) antidepressant used primarily to treat major depressive disorder by increasing serotonin levels in the brain.
It blocks the serotonin transporter (SERT), raising serotonin in synapses, which over weeks helps normalize mood, energy, and sleep.
FDA-approved for major depressive disorder; clinicians may also use it off-label for anxiety disorders, panic disorder, and OCD when appropriate.
Some people notice improvements in sleep or appetite within 1–2 weeks; mood, motivation, and interest usually improve by 4–8 weeks.
Commonly 20 mg once daily, with possible increase to 40 mg daily. Maximum is 20 mg daily in adults over 60, those with liver impairment, or taking strong CYP2C19 inhibitors, due to QT prolongation risk.
Take it at the same time daily. If it causes sleepiness, try evening; if it’s activating or affects sleep, try morning.
Nausea, dry mouth, sweating, tremor, headache, insomnia or drowsiness, and sexual dysfunction. Many effects ease after the first few weeks.
Weight change is typically modest. Some gain or loss can occur; lifestyle habits and duration of treatment influence this.
At higher doses, citalopram can prolong the QT interval, rarely leading to torsades de pointes. Doses above 40 mg are not recommended; ECG and electrolyte checks are prudent in at-risk patients.
Serotonin syndrome (especially with other serotonergic drugs), severe hyponatremia (SIADH), abnormal bleeding (with NSAIDs/anticoagulants), angle-closure glaucoma in predisposed individuals, and increased suicidal thoughts in young people.
Do not combine with MAOIs, linezolid, or methylene blue. Avoid pimozide and use caution with other QT-prolonging agents. Omeprazole, cimetidine, and other CYP2C19 inhibitors can raise citalopram levels. Be cautious with triptans, tramadol, St. John’s wort, lithium, and other serotonergic drugs.
Alcohol can worsen drowsiness, impair judgment, and aggravate depression. Avoid or minimize alcohol while taking citalopram.
Do not stop abruptly. Taper slowly with your prescriber to reduce discontinuation symptoms such as dizziness, irritability, flu-like feelings, and sleep disturbance.
SSRIs can be used when benefits outweigh risks. Potential risks include neonatal adaptation symptoms and, rarely, PPHN. In breastfeeding, small amounts pass into milk; many infants do well with monitoring. Decisions are individualized with your clinician.
Your clinician may check an ECG if you have cardiac risk factors or are on QT-prolonging drugs, and monitor electrolytes (potassium, magnesium) and sodium if indicated.
Take it when remembered unless it’s close to the next dose; don’t double up. Resume your regular schedule.
Yes. Reduced libido, delayed orgasm, or anorgasmia can occur. Dose adjustments, timing strategies, or adjunctive treatments may help—discuss with your clinician.
Yes, citalopram oral solution is available. Standard tablets can also be split if scored; do not crush or split unless advised.
Overdose can cause nausea, drowsiness, tremor, rapid heartbeat, seizures, and dangerous heart rhythm changes. Seek emergency help immediately.
Escitalopram is the active S-enantiomer and is slightly more potent milligram-for-milligram, with some studies showing faster or greater symptom relief. Both are well tolerated; citalopram has a higher dose-related QT risk at upper doses.
Both are similar. Escitalopram may have slightly fewer side effects at equivalent efficacy, particularly less fatigue or GI upset in some patients. Individual response varies.
Sertraline has strong evidence and approvals for multiple anxiety disorders and OCD. Citalopram can help anxiety but is not officially approved. Choice depends on symptoms, tolerability, and history.
Sertraline may cause more early GI symptoms (nausea, diarrhea) and can be more activating. Citalopram tends to be more neutral but carries greater QT concerns at higher doses.
Fluoxetine is generally more energizing and has a long half-life, which lowers discontinuation risk but raises drug–drug interaction potential. Citalopram is more neutral and has fewer CYP interactions.
Fluoxetine’s long half-life provides a “forgiveness” buffer if doses are missed and can simplify discontinuation. Citalopram requires more consistent daily dosing and gradual tapering.
Paroxetine is more likely to cause weight gain, sedation, anticholinergic effects (dry mouth, constipation), and sexual dysfunction. Citalopram is often better tolerated in these domains.
Paroxetine’s short half-life leads to more intense withdrawal symptoms if stopped abruptly. Citalopram can also cause discontinuation effects, but typically milder with a proper taper.
Fluvoxamine is a strong inhibitor of CYP1A2 and CYP2C19, causing many interactions. Citalopram has a cleaner interaction profile but is sensitive to CYP2C19 inhibitors that raise its levels.
Typical citalopram dosing is 20–40 mg daily (max 20 mg in older adults or with risk factors). Escitalopram is 10–20 mg daily, reflecting higher potency of the S-enantiomer.
Citalopram has a clearer dose-dependent QT prolongation risk, limiting doses to 40 mg (or 20 mg in higher-risk groups). Sertraline has a lower QT risk and is often preferred in patients with cardiac concerns.
Fluoxetine strongly inhibits CYP2D6 and has numerous interactions with other medications. Citalopram has fewer CYP-mediated interactions but interacts with QT-prolonging agents and CYP2C19 inhibitors.
Both can be used; escitalopram often preferred due to potency and tolerability. For citalopram, the maximum dose in older adults is 20 mg because of QT risk, and ECG monitoring may be considered.
Sertraline is often considered first-line in pregnancy and breastfeeding due to the most extensive safety data. Citalopram can be used when clinically indicated, with individualized risk–benefit assessment.
Fluvoxamine and sertraline have strong approvals for OCD. Citalopram may help but is typically not first-line for OCD compared with those agents.
Fluoxetine may feel more energizing early, but both SSRIs generally take 4–8 weeks for full antidepressant effects. Individual variation is common.